-+ 0.00%
-+ 0.00%
-+ 0.00%

KALARIS THERAPEUTICS REPORTS POSITIVE INITIAL PHASE 1A DATA FOR TH103 IN TREATMENT-NAÏVE NEOVASCULAR AMD

Reuters·12/17/2025 21:01:11

Please log in to view news